Strata Critical Medical, Inc. Class A Common Stock SRTA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $254.27M+14.1% | $222.83M+15.8% | $192.44M+7.4% | $179.2M+1.6% | $176.34M-8.1% | ||
| $199.13M+13.9% | $174.76M+15.7% | $151.02M+6.4% | $141.89M+1.0% | $140.41M-8.2% | ||
| $55.14M+14.7% | $48.07M+16.1% | $41.42M+11.0% | $37.31M+3.8% | $35.93M-7.9% | ||
| 21.7%+0.1pp | 21.6%+0.1pp | 21.5%+0.7pp | 20.8%+0.4pp | 20.4%0.0pp | ||
| —— | —— | —— | —— | $50.47M-0.8% | ||
| $7.97M+15.6% | $6.9M+64.1% | $4.2M+49.4% | $2.81M+108% | $1.35M+7.4% | ||
| —— | —— | —— | —— | $51.82M-0.6% | ||
| —— | —— | —— | —— | $51.82M-0.6% | ||
| -$19.96M+12.0% | -$22.67M-2.3% | -$22.17M+6.2% | -$23.64M+23.3% | -$30.83M+11.9% | ||
| -7.8%+2.3pp | -10.2%+1.3pp | -11.5%+1.7pp | -13.2%+4.3pp | -17.5%+0.8pp | ||
| $3.39M-20.0% | $4.24M-18.3% | $5.19M-10.9% | $5.83M-9.8% | $6.46M-10.4% | ||
| $3.59M+57.0% | $2.29M— | —— | —— | —— | ||
| -$16.37M+19.7% | -$20.38M+9.1% | -$22.42M-21.9% | -$18.39M+29.1% | -$25.94M+9.4% | ||
| $21K0.0% | $21K0.0% | $21K0.0% | $21K-59.6% | $52K+263% | ||
| —— | —— | $40.39M+313% | -$18.98M+28.5% | -$26.57M+2.7% | ||
| -$20,065,999.950.0% | -$20,066,000.00+9.2% | -$22,108,000.00-22.3% | -$18,078,000.00— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $0.49+304% | -$0.24+29.4% | -$0.34+5.6% | ||
| —— | —— | $0.49+304% | -$0.24+29.4% | -$0.34+5.6% | ||
| 336M+3.2% | 325.7M+1.4% | 321.1M+1.4% | 316.7M+1.2% | 313M+1.3% | ||
| 331.2M+1.7% | 325.7M+1.4% | 321.1M+1.4% | 316.7M+1.2% | 313M+1.3% | ||
| —— | —— | —— | —— | $0— | ||
| $3.39M-20.0% | $4.24M-18.3% | $5.19M-10.9% | $5.83M-9.8% | $6.46M-10.4% | ||
| -$0.19+20.8% | -$0.24+14.3% | -$0.28-21.7% | -$0.23— | —— | ||
| -$0.19+20.8% | -$0.24+14.3% | -$0.28-21.7% | -$0.23— | —— | ||
| —— | —— | —— | —— | $1.35M+7.4% | ||
| -$16.05M+20.0% | -$20.07M+9.2% | -$22.11M-22.3% | -$18.08M— | —— | ||
| $254.27M+14.1% | $222.83M+15.8% | $192.44M+7.4% | $179.2M+1.6% | $176.34M-8.1% | ||
| -$19.96M+12.0% | -$22.67M-2.3% | -$22.17M+6.2% | -$23.64M+23.3% | -$30.83M+11.9% | ||
| -$10.41M+28.1% | -$14.48M+6.3% | -$15.46M+10.9% | -$17.35M+29.9% | -$24.77M+14.8% | ||
| -$10.41M+28.1% | -$14.48M+6.3% | -$15.46M+10.9% | -$17.35M+29.9% | -$24.77M+14.8% | ||
| -4.1%+2.4pp | -6.5%+1.5pp | -8%+1.7pp | -9.7%+4.4pp | -14%+1.1pp | ||
| -$19.96M+12.0% | -$22.67M-2.3% | -$22.17M+6.2% | -$23.64M+23.3% | -$30.83M+11.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Strata Critical Medical, Inc. Class A Common Stock's revenue?
- Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated $254.3M in revenue over the trailing twelve months, up 44.2% year over year.
- Is Strata Critical Medical, Inc. Class A Common Stock profitable?
- Strata Critical Medical, Inc. Class A Common Stock reported $52.3M in net income over the trailing twelve months, a 21.0% net margin.
- What are Strata Critical Medical, Inc. Class A Common Stock's profit margins?
- Gross margin is 21.7% and operating margin is -7.8%, with a 21.0% net margin.
- What is Strata Critical Medical, Inc. Class A Common Stock's earnings per share?
- Strata Critical Medical, Inc. Class A Common Stock's diluted EPS over the trailing twelve months is $0.64.
- Where does Strata Critical Medical, Inc. Class A Common Stock's income statement data come from?
- Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
